Extract from the Register of European Patents

EP About this file: EP0215050

EP0215050 - PURIFICATION OF BLOOD COAGULATION FACTOR VIII BY PRECIPITATION [Right-click to bookmark this link]
StatusOpposition rejected
Status updated on  19.04.1995
Database last updated on 11.04.2026
Most recent event   Tooltip05.10.2005Change: Appeal number 
Applicant(s)For all designated states
National Blood Authority
Oak House, Reeds Crescent
Watford, Herts. WD1 1QH / GB
[1993/48]
Former [1987/13]For all designated states
Central Blood Laboratories Authority
"The Crest", Dagger Lane, Elstree
Boreham Wood, Hertfordshire, WD6 3AU / GB
Inventor(s)01 / WINKELMAN, Lowell 69 Old High Street
Headington
Oxford / GB
[1987/13]
Representative(s)Holmes, Michael John, et al
Frank B. Dehn & Co. St Bride's House 10 Salisbury Square
London EC4Y 8JD / GB
[N/P]
Former [1988/25]Holmes, Michael John, et al
Frank B. Dehn & Co. European Patent Attorneys Imperial House 15-19 Kingsway
London, WC2B 6UZ / GB
Former [1987/13]Lockwood, Peter Brian
Procurement Executive Ministry of Defence Patents 1 A (4) Room 2014, Empress State Building Lillie Road
London SW6 1TR / GB
Application number, filing date86901470.406.03.1986
[1987/13]
WO1986GB00121
Priority number, dateGB1985000588207.03.1985         Original published format: GB 8505882
[1987/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO8605190
Date:12.09.1986
Language:EN
[1986/20]
Type: A1 Application with search report 
No.:EP0215050
Date:25.03.1987
Language:EN
The application published by WIPO in one of the EPO official languages on 12.09.1986 takes the place of the publication of the European patent application.
[1987/13]
Type: B1 Patent specification 
No.:EP0215050
Date:06.02.1991
Language:EN
[1991/06]
Search report(s)International search report - published on:EP12.09.1986
ClassificationIPC:C07K3/24, A61K37/02, A61K35/16
[1987/13]
CPC:
C07K14/755 (EP,US); A61P7/04 (EP); A61K38/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   IT,   LI,   LU,   NL,   SE [1987/13]
TitleGerman:REINIGUNG DES BLUTGERINNUNGSFAKTORS-VIII DURCH FÄLLUNG[1987/13]
English:PURIFICATION OF BLOOD COAGULATION FACTOR VIII BY PRECIPITATION[1987/13]
French:PURIFICATION DU FACTEUR DE COAGULATION SANGUINE VIII PAR PRECIPITATION[1987/13]
Entry into regional phase10.11.1986National basic fee paid 
10.11.1986Designation fee(s) paid 
10.11.1986Examination fee paid 
Examination procedure10.11.1986Examination requested  [1987/13]
28.12.1987Despatch of a communication from the examining division (Time limit: M06)
28.06.1988Reply to a communication from the examining division
03.05.1989Despatch of a communication from the examining division (Time limit: M04)
26.06.1989Reply to a communication from the examining division
21.03.1990Despatch of communication of intention to grant (Approval: Yes)
02.08.1990Communication of intention to grant the patent
30.10.1990Fee for grant paid
30.10.1990Fee for publishing/printing paid
Opposition(s)Opponent(s)01  01.11.1991  09.12.1991  ADMISSIBLE
IMMUNO Aktiengesellschaft
Industriestrasse 67
A-1221 Wien / AT
Opponent's representative
Wolfram, Gustav
Patentanwälte Sonn, Pawloy, Weinzinger & Wolfram, Riemergasse 14
1010 Wien / AT
 02  04.11.1991  21.11.1991  ADMISSIBLE
Fondation Nationale de transfusion sanguine
6, rue Alexandre-Cabanel
F-75739 Paris Cedex 15 / FR
Opponent's representative
Warcoin, Jacques
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
 [N/P]
Former [1992/01]
Opponent(s)01  01.11.1991  09.12.1991  ADMISSIBLE
IMMUNO Aktiengesellschaft
Industriestrasse 67
A-1221 Wien / AT
Opponent's representative
Wolfram, Gustav, Dipl.-Ing.
Patentanwälte Sonn, Pawloy, Weinzinger & Wolfram, Riemergasse 14
A-1010 Wien / AT
 02  04.11.1991  21.11.1991  ADMISSIBLE
Fondation Nationale de transfusion sanguine
6, rue Alexandre-Cabanel
F-75739 Paris Cedex 15 / FR
Opponent's representative
Warcoin, Jacques
Cabinet Régimbeau, 26, avenue Kléber
F-75116 Paris / FR
Former [1991/52]
Opponent(s)01  01.11.1991  09.12.1991  ADMISSIBLE
IMMUNO Aktiengesellschaft
Industriestrasse 67
A-1221 Wien / AT
Opponent's representative
Wolfram, Gustav, Dipl.-Ing.
Patentanwälte Sonn, Pawloy, Weinzinger & Wolfram, Riemergasse 14
A-1010 Wien / AT
12.12.1991Invitation to proprietor to file observations on the notice of opposition
22.04.1992Reply of patent proprietor to notice(s) of opposition
02.06.1993Date of oral proceedings
21.10.1993Despatch of minutes of oral proceedings
21.10.1993Date of despatch of rejection of opposition
01.04.1995Legal effect of rejection of opposition [1995/23]
Appeal following opposition09.12.1993Appeal received No.  T1069/93
18.02.1994Statement of grounds filed
30.03.1995Result of appeal procedure: appeal of the opponent withdrawn
Fees paidRenewal fee
22.03.1988Renewal fee patent year 03
21.03.1989Renewal fee patent year 04
21.03.1990Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]   Biological Abstracts, Volume 63, No. 9, 1 May 1977, Philadelphia, PA (US) A. BUKURESTLIEV et al.: "Production of a more Protent Factor VIII Preparation" see page 4815, Abstract 48885, & Folia Haematol. (Leipzig) 103 (5): 742-745, 1976 (recd. 1977) [X]
Examination  Biological Abstracts, vo. 63, no. 9, 01 May 1977, Piladelphia, PA(US); A.BUKURESTLIEV et al.: "Production of a more potent factor VIII preparation" , see p.4815,abstracts 48885.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.